Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer

NCT04465097 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tucidinostat
DRUG: Exemestane
DRUG: Ovarian function suppression

Sponsor

First Affiliated Hospital, Sun Yat-Sen University